DNA and mRNA Vaccines
A section of Vaccines (ISSN 2076-393X).
Aim and Scope
The developments of Omics sciences impacted Health and Life Sciences. In the fields of Immunology and Vaccination, these developments paved the way to broaden the use of immunization strategies. While traditionally vaccines have been based on attenuated pathogens or parts of them to stimulate the immune system, the development of Omics has broadened this usage to DNA and mRNA in novel immunological strategies against infectious and non-infectious diseases. While DNA vaccines have achieved some success, particularly in veterinary applications, the COVID-19 pandemic has led to a worldwide race for protective mRNA-based vaccines to reach the market in a timeframe never seen before.
This section is intended to cover all relevant topics related to DNA and mRNA vaccines for both infectious and non-infectious diseases, ranging from the rational design to the development and production of preclinical and clinical applications. While human therapeutics is of particular interest, manuscripts on animal therapeutics are also welcome.
Topical Advisory Panel
Following special issues within this section are currently open for submissions:
- RNA-Based Therapeutics for the Development of Prophylactic and Therapeutic Vaccines (Deadline: 20 October 2023)
- Next Generation Sequencing: A Promising Tool for Vaccines and Other Biological Products (Deadline: 10 November 2023)
- DNA Vaccines against Infectious Diseases (Deadline: 28 November 2023)
- Towards Protein Structure and Functional Analysis in Coronavirus and Therapeutic Perspectives (Deadline: 30 November 2023)
- Feature Papers of DNA and mRNA Vaccines (Deadline: 31 January 2024)
- Computer-Aided Vaccinology: From Epitope Prediction to Reverse Vaccinology and Beyond (Deadline: 31 January 2024)
- mRNA-Based Vaccine Development (Deadline: 31 January 2024)
- Selected Papers from the 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments (IECV2023) (Deadline: 30 June 2024)
- Nanoparticle Based Vaccines (Deadline: 30 June 2024)
- Vaccinomics: Omics-System Biology Approach in Vaccine Development (Deadline: 1 July 2024)
- Advances in Vector-Based Immunization: Exploring the Next Frontier of Vaccine Technology. (Deadline: 31 July 2024)
- Recent Discoveries and Developments in RNA and DNA Vaccines (Deadline: 8 September 2024)